BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33272859)

  • 1. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities associated with Medicare Part D Star Ratings measures among patients with Alzheimer's disease and related dementias.
    Tsang CCS; Zhang X; Barenie RE; Cernasev A; Miller NA; Wan JY; Tsao JW; Wang J
    Medicine (Baltimore); 2023 May; 102(18):e33641. PubMed ID: 37144996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.
    Browning J; Tsang CCS; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Wang J
    J Am Pharm Assoc (2003); 2022; 62(1):142-149. PubMed ID: 34509379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.
    Dong X; Tsang CCS; Browning JA; Sim Y; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J
    Curr Med Res Opin; 2023 Jul; 39(7):963-971. PubMed ID: 37219396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and ethnic disparities due to Medicare Part D Star Ratings criteria among kidney transplant patients with diabetes, hypertension, and/or dyslipidemia.
    Chisholm-Burns MA; Spivey CA; Tsang CCS; Wang J
    J Manag Care Spec Pharm; 2022 Jun; 28(6):688-699. PubMed ID: 35621720
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of Part D Star Ratings on racial and ethnic disparities in health care costs.
    Tsang CCS; Sim Y; Christensen ML; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100250. PubMed ID: 37091627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing racial/ethnic disparities associated with Medicare Part D Star Ratings among population with Alzheimer's disease and related dementias.
    Tsang CCS; Wang J
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1067-1075. PubMed ID: 37551695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
    Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
    Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
    Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
    J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of star ratings bonus payments on disparities in medication utilization issues.
    Tsang CCS; Garuccio J; Dong X; Sim Y; Wang J
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100323. PubMed ID: 37694164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
    Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
    Wang J; Brown LM; Hong SH
    J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
    Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
    JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Medicare Advantage Star Ratings With Racial, Ethnic, and Socioeconomic Disparities in Quality of Care.
    Meyers DJ; Rahman M; Mor V; Wilson IB; Trivedi AN
    JAMA Health Forum; 2021 Jun; 2(6):e210793. PubMed ID: 35977175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.